---
title: Clinilabs vs CMIC HOLDINGS Co., Ltd.
slug_a: clinilabs
slug_b: cmicgroup
site: cro
review_signal_gate: closed
canonical_path: /compare/clinilabs/cmicgroup
---

# Clinilabs vs CMIC HOLDINGS Co., Ltd.

Side-by-side profile data from each company listing on this directory.

## Clinilabs

- Profile: [/companies/clinilabs](/companies/clinilabs)

Clinilabs — Clinilabs is the leading CNS-focused CRO with 25+ years of expertise in neurotherapeutic clinical trials, offering Phase 1–4 trial management, early-phase development, clinical research units, and MedTech device expertise across psychiatry, neurology, substance use, and rare CNS disorders.

Services: 11. Modalities: 0. Indications: 3. Locations: 6. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- CNS Specialty Services
- Device & Combination Product Services

### Modalities

- Data not yet provided.

### Indications

- Neurology
- Psychiatry
- Rare Disease

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## CMIC HOLDINGS Co., Ltd.

- Profile: [/companies/cmicgroup](/companies/cmicgroup)

CMIC HOLDINGS Co., Ltd. — CMIC HOLDINGS is a Japanese healthcare group whose Pharmaceutical Solutions cover consulting, non-clinical CRO, CRO, CDMO, SMO and CSO services. The group says it supports pharmaceutical companies across the value chain from non-clinical stages through post-marketing.

Services: 11. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)